The presence of hereditary low-risk thrombophilia (such as heterozygosity for FVL or prothrombin G20210A mutation) seems to have a greater effect than acquired thrombophilia or other dispositional risk factors on procoagulant activity in pregnancy. The gene discussed is F2; the disease is thrombophilia.